NEWS & EVENTS
List
Icon
-
Zhunan Site Dedicated Oncology(Cytotoxic) Azacitidine API Plant obtained EU GMP (QPD) Compliance Article 46(f) of Directive 2001/83/EC and Article 50(f) of Directive 2001/82/ECMORE > -
Zhunan Site Dedicated Oncology(Cytotoxic) Ponatinib API Plant obtained Taiwan FDA PIC/S GMP Certification.MORE > -
BioSpectrum Asia granted GBC the Excellence Award "Top Company in API Development"!MORE > -
Tainan Site has been approved by Taiwan FDA PIC/S GMDP Follow-up Inspection (Medicinal product/ Drug product)MORE > -
Taiwan FDA granted the peptide API Market License of Teriparatide "GBC"MORE > -
Taiwan FDA granted Market License of Gemcitabine Lyo. Injection 200mg "GBC"MORE >